Stocks
USANA Health Sciences (USNA) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 192.9 | 130.2 | 123.1 | 98.9 | 82.1 | 78.3 | ||
| Changes by years, y/y, % | -4% | -32% | -5% | -20% | -17% | -16.4% | |||
USANA Health Sciences. EBITDA US GAAP, bln rub
USANA Health Sciences. EBITDA US GAAP, changes, %
USANA Health Sciences. EBITDA US GAAP, sum by quarters, bln rub
USANA Health Sciences (USNA) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 27.4 | 28.7 | 11.4 | 14.6 | 23.7 | 78.3 | |
| Changes by years, y/y, % | -15% | +22% | -53% | -11% | -14% | |||
| Changes by quarters, q/q, % | +67% | +5% | -60% | +28% | +62% | |||
